Cochlear | COH - Frais De Vente Et D'Administration

Prix De L'Action
185.00
Variation Quotidienne
-0.83 -0.45%
Mensuellement
-26.05%
Annuel
-32.82%
Q1 Prévisions
191.63




Frais De Vente Et D'Administration Changement Date
Ansell USD 274.8M 7.6M 2025-12
Avita Medical AUD 19.03M 1.95M 2025-12
Cochlear AUD 449.4M 214.45M 2025-12
CSL USD 1.23B 498M 2025-12
Fisher Paykel Healthcare NZD 285.5M 11.6M 2025-12
Healius AUD 393.4M 378.35M 2024-12
Integral Diagnostics AUD 169.98M 18.73M 2024-06
Mayne Pharma AUD 54.8M 11.94M 2024-06
Mesoblast USD 28.54M 9.69M 2025-12
Monash IVF AUD 33.08M 26.76M 2025-12
Nanosonics AUD 53.78M 26.93M 2025-12
Polynovo AUD 21.13M 18.27M 2024-06
Ramsay Health Care AUD 5.29B 3.2M 2024-12
Regis Healthcare AUD 61.19M 444.23M 2025-12
ResMed USD 275.7M 16.51M 2025-12
Sigma Healthcare AUD 134.77M 9.73M 2024-12
Somnomed AUD 19.5M 353.23K 2023-06
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Telix Pharmaceuticals AUD 93.48M 1.04M 2025-12